Abbott India Limited (NSE:ABBOTINDIA)
India
· Delayed Price · Currency is INR 29,597
-199 (-0.67%)
Mar 13, 2025, 3:29 PM IST
Abbott India Revenue
Abbott India had revenue of 16.14B INR in the quarter ending December 31, 2024, with 12.33% growth. This brings the company's revenue in the last twelve months to 62.43B, up 8.51% year-over-year. In the fiscal year ending March 31, 2024, Abbott India had annual revenue of 58.49B with 9.35% growth.
Revenue (ttm)
62.43B
Revenue Growth
+8.51%
P/S Ratio
n/a
Revenue / Employee
16.37M
Employees
3,814
Market Cap
629.18B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 58.49B | 5.00B | 9.35% |
| Mar 31, 2023 | 53.49B | 4.35B | 8.86% |
| Mar 31, 2022 | 49.13B | 6.03B | 14.00% |
| Mar 31, 2021 | 43.10B | 2.17B | 5.30% |
| Mar 31, 2020 | 40.93B | 4.15B | 11.27% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 516.03B |
| Divi's Laboratories | 90.78B |
| Cipla | 267.20B |
| Mankind Pharma | 116.41B |
| Zydus Lifesciences | 222.47B |
| Apollo Hospitals Enterprise | 211.46B |
| Aurobindo Pharma | 309.22B |
| Alkem Laboratories | 127.57B |
Abbott India News
- 5 weeks ago - Abbott India shares surge 3% as net profit jumps 16% YoY to Rs 360.8 crore in Q3 - Business Upturn
- 7 weeks ago - Pharma stocks: Glenmark up 1.57%, Glaxo gains 1.31%, Mankind Pharma declines 2.84% - Business Upturn
- 2 months ago - Pharma Stocks Today: Biocon surges 4.41%, Mankind Pharma up 1.85%; Glaxo and Abbott India decline - Business Upturn
- 2 months ago - Stock Market Update, January 7: Apollo Hospitals, Apar Industries, Abbott India, Amber Enterprises and more hit 52-week highs today - Business Upturn
- 3 months ago - Pharma Stocks: Cipla down nearly 2%, Ajanta Pharma down 1.45%, Abbott India up 1.27% - Business Upturn
- 3 months ago - Abbott India launches 14-Valent Pneumococcal Conjugate vaccine offering broad protection for children - Business Upturn
- 4 months ago - Abbott India shares fall nearly 4% following Q2 results - Business Upturn
- 4 months ago - Abbott India Q2 FY25 Results: Revenue up 9.3% YoY to ₹1,632.67 crore, Net Profit rises 14.6% YoY - Business Upturn